grant

Late Pathologies of Exposure to Repetitive Head Impacts from Contact Sports: White Matter and Vascular Contributions to Cognitive Impairment, Dementia, and Neuropsychiatric Symptoms

Organization BOSTON UNIVERSITY MEDICAL CAMPUSLocation BOSTON, UNITED STATESPosted 15 Sept 2021Deadline 31 Aug 2026
NIHUS FederalResearch GrantFY2025AD dementiaAD related dementiaADRDAdverse Late EffectsAffectAgeAgreementAlzheimer Type DementiaAlzheimer beta-ProteinAlzheimer disease dementiaAlzheimer sclerosisAlzheimer syndromeAlzheimer'sAlzheimer's Amyloid beta-ProteinAlzheimer's DiseaseAlzheimer's amyloidAlzheimer's and related dementiasAlzheimer's dementia and related dementiaAlzheimer's dementia or related dementiaAlzheimer's disease and related dementiaAlzheimer's disease and related disordersAlzheimer's disease or a related dementiaAlzheimer's disease or a related disorderAlzheimer's disease or related dementiaAlzheimer's disease related dementiaAlzheimers DementiaAmentiaAmericanAmyloid Alzheimer's Dementia Amyloid ProteinAmyloid Beta-PeptideAmyloid Protein A4Amyloid beta-ProteinAmyloid βAmyloid β-PeptideAmyloid β-ProteinAnteriorArteriolosclerosesAxonBBB disruptionBiological MarkersBloodBlood PlasmaBlood Reticuloendothelial SystemBlood VesselsBostonBrainBrain Nervous SystemBrain TraumaBrain Vascular DisordersCD106CD106 AntigensCaliforniaCausalityCerebral Amyloid AngiopathyCerebrovascular DiseaseCerebrovascular DisordersClinicalClinico-Pathologic ConferenceClinico-Pathological ConferenceCognitionCognitiveCognitive DisturbanceCognitive ImpairmentCognitive declineCognitive deficitsCognitive function abnormalCollaborationsCongophilic AngiopathyDWI (diffusion weighted imaging)DWI-MRIDataData SetDegenerative Neurologic DisordersDementiaDepositDepositionDiffusion MRIDiffusion Magnetic Resonance ImagingDiffusion Weighted MRIDiffusion weighted imagingDiffusion-weighted Magnetic Resonance ImagingDisturbance in cognitionDoseELISAEncephalonEnrollmentEnzyme-Linked Immunosorbent AssayEtiologyEvaluationExecutive DysfunctionExecutive Function DeficitExecutive ImpairmentExposure toFe elementFemaleFootballFrequenciesHistoryINCAM-110ImmunofluorescenceImmunofluorescence ImmunologicImpaired cognitionImpairmentInducible Cell Adhesion Molecule 110InjuryInterventionInterviewIntracranial Vascular DiseasesIntracranial Vascular DisordersIronLate EffectsLightLiteratureLumbar PunctureMR ImagingMR TomographyMRIMRIsMT-bound tauMagnetic Resonance ImagingManufactured footballMapsMedical Imaging, Magnetic Resonance / Nuclear Magnetic ResonanceMemoryMental DepressionMyelinMyelin Basic ProteinsNMR ImagingNMR TomographyNervous System Degenerative DiseasesNeural Degenerative DiseasesNeural degenerative DisordersNeurodegenerative DiseasesNeurodegenerative DisordersNeurologic Degenerative ConditionsNuclear Magnetic Resonance ImagingOligodendrocytesOligodendrocytusOligodendrogliaOligodendroglia CellOutcomePARK5Parkinson disease 5 geneParticipantPathologicPathologyPersonsPhonePhotoradiationPlasmaPlasma SerumPlayPositionPositioning AttributePredispositionPrimary Senile Degenerative DementiaProtocolProtocols documentationRaceRacesRecording of previous eventsReportingResearchReticuloendothelial System, Serum, PlasmaRiskRisk FactorsSamplingSan FranciscoSeveritiesSpinal PunctureSportsSubgroupSusceptibilitySymptomsSyndromeTelephoneTestingThickThicknessTraumatic Brain InjuryTraumatic encephalopathyUCHL1UCHL1 geneUniversitiesVCAMVCAM-1VEGFVEGFsVascular Cell Adhesion MoleculeVascular Cell Adhesion Molecule-1Vascular Cognitive ImpairmentVascular Endothelial Growth FactorsWhite Matter HyperintensityZeugmatographya beta peptideabetaagesamyloid betaamyloid-b proteinarterial spin labelingarterial spin taggingaxon damageaxon injuryaxonal damageaxonal injurybeta amyloid fibrilbio-markersbiologic markerbiomarkerbiomarker identificationblood-brain barrier disruptionbloodbrain barrier disruptionbrain vascular diseasebrain vascular dysfunctioncausationcerebral vascular diseasecerebral vascular dysfunctioncerebrovascular amyloidosiscerebrovascular contribution to cognitive impairmentcerebrovascular contributions to cognitive dysfunctioncerebrovascular dysfunctionchronic traumatic encephalopathyclinical conferencecognitive defectscognitive dysfunctioncognitive losscohortcollision sportscontact sportsdMRIdegenerative diseases of motor and sensory neuronsdegenerative neurological diseasesdementia riskdensitydepressiondiffusion tensor imagingdisease causationdosageenrollenzyme linked immunoassayexecutive controlexecutive functionfocus on malefocused on menhead impacthistorieshypoperfusionidentification of biomarkersidentification of new biomarkersin vivoindexinginformantinjuriesintracranial vascular dysfunctionlater in lifelater lifemalemale focusedmale specificmale targetedmarker identificationmicrotubule bound taumicrotubule-bound taumicrovascular pathologyneurobehavioralneurodegenerative illnessneurofilamentneuropsychiatricneuropsychiatric symptomneuropsychiatrynovelp-taup-τphospho-tauphospho-τphosphorylated taupost-translational modification of tauposttranslational modification of tauprimary degenerative dementiaracialracial backgroundracial originrecruitresilience factorresiliency factorresponserisk factor for dementiarisk for dementiasenile dementia of the Alzheimer typesexsoluble amyloid precursor proteinsubstantia albatargeted to mentautau Proteinstau factortau phosphorylationtau posttranslational modificationtau-1traumatic brain damagevascularvascular and cognitive impairmentvascular cognition impairmentvascular cognitive declinevascular cognitive diseasevascular cognitive disordervascular cognitive dysfunctionvascular contributionsvascular contributions to cognitive declinevascular contributions to cognitive impairmentvascular disease and impaired cognitionvascular dysfunction resulting in cognitive declinevascular related cognitive declinevascular related cognitive impairmentvascular risk factorwhite matterτ Proteinsτ phosphorylation
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Each year, millions of Americans are exposed to repetitive head impacts (RHI) through contact sport participation
and may be at risk for chronic traumatic encephalopathy (CTE). The clinical presentation of CTE is ill-defined

and includes deficits in executive function and memory, dementia, neurobehavioral dysregulation and

depression. While these clinical features have been attributed to phosphorylated tau (p-tau) pathology, our data

show p-tau is not related to neuropsychiatric symptoms and does not account for all cognitive deficits in CTE.

The etiology of these clinical features is thus unclear and likely multifactorial. Our data in small samples of male

football players show that white matter (WM) degeneration and cerebrovascular disease (CBVD) are common

and affect cognition. Yet, the vascular contributions to neuropsychiatric syndromes and cognitive impairment

and dementia (VCID) in former contact sport athletes are unknown and a topic that our existing studies do not

address. This R01 will conduct sophisticated in vivo and ex vivo assessments of WM integrity and CBVD and

examine risk factors for, and the cognitive and neuropsychiatric effects of WM degeneration and CBVD in living

and deceased former contact sport athletes. In a collaborative effort between the Boston University (BU) and

Univ. of California, San Francisco (UCSF) Alzheimer's Disease Research Centers (ADRCs), we will recruit 200

former contact sport athletes (>50 years), males and females from different sports, and 100 age- and race-

matched people with no history of RHI or traumatic brain injury (TBI). Groups will span the cognitive continuum.

Participants will enroll into the BU or UCSF ADRC to complete cognitive and neuropsychiatric tests, advanced

MRI protocols of WM integrity and CBVD, and blood draw for plasma biomarker analysis of WM integrity and

CBVD. A subgroup (50 former contact sport athletes, 25 non-RHI/TBI) will undergo lumbar puncture to test

plasma-CSF analyte concordance and examine novel CSF microvascular markers. We will expand our U54 of

7 harmonized brain banks studying RHI and AD/ADRD risk by adding novel ELISA, multiplex

immunofluorescence, and CLARITY pathological assessments of WM integrity (myelin integrity and thickness,

oligodendrocyte and axonal loss) and CBVD (vessel density, size, and branch points) on 200 deceased contact

sport athletes (varying in RHI exposure and age) and 100 age-/race-matched non-RHI/TBI donors. Harmonized

pathological protocols, informant interviews and clinicopathological conferences are done across all brain banks.

Data from this R01 will be used to test our hypotheses that RHI exposure is associated with WM degeneration

and CBVD; these pathologies independently contribute to executive dysfunction, neurobehavioral dysregulation

and depression; and RHI (e.g., type of sport played) and non-RHI (e.g., vascular risk) factors are effect modifiers.

This R01 will lead to unprecedented data sets to increase understanding of the risk for cognitive and

neuropsychiatric impairment from WM degeneration and CBVD in former contact sport athletes. Data will inform

on symptom etiology and open the door to intervention and preventative targets for the millions exposed to RHI.

Grant Number: 5R01NS122854-03
NIH Institute/Center: NIH

Principal Investigator: Michael Alosco

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →